TY - JOUR
T1 - Approach and management of checkpoint inhibitor-related immune hepatitis
AU - Sanjeevaiah, Aravind
AU - Kerr, Thomas
AU - Beg, Muhammad Shaalan
N1 - Publisher Copyright:
© Journal of Gastrointestinal Oncology.
PY - 2018/2/1
Y1 - 2018/2/1
N2 - Immune checkpoint inhibitors have promising clinical activity across multiple gastrointestinal cancers and immune-mediated hepatotoxicity is particularly relevant for this group of patients. In this article we will review the recognition, workup and management of suspected checkpoint inhibitor related immunehepatitis.
AB - Immune checkpoint inhibitors have promising clinical activity across multiple gastrointestinal cancers and immune-mediated hepatotoxicity is particularly relevant for this group of patients. In this article we will review the recognition, workup and management of suspected checkpoint inhibitor related immunehepatitis.
KW - Gastrointestinal cancers
KW - Immune checkpoint inhibitors
KW - Immune-mediated toxicity
KW - Immunotherapy
UR - http://www.scopus.com/inward/record.url?scp=85041701184&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85041701184&partnerID=8YFLogxK
U2 - 10.21037/jgo.2017.08.14
DO - 10.21037/jgo.2017.08.14
M3 - Article
C2 - 29564187
AN - SCOPUS:85041701184
SN - 2078-6891
VL - 9
SP - 220
EP - 224
JO - Journal of Gastrointestinal Oncology
JF - Journal of Gastrointestinal Oncology
IS - 1
ER -